Skip to main content
Journal cover image

DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL

Publication ,  Conference
Desjardins, A; Peters, KB; Vredenburgh, JJ; Friedman, HS; Reardon, DA
Published in: NEURO-ONCOLOGY
November 1, 2010

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

November 1, 2010

Volume

12

Start / End Page

51 / 51

Location

Hollywood, FL

Publisher

OXFORD UNIV PRESS INC

Conference Name

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Peters, K. B., Vredenburgh, J. J., Friedman, H. S., & Reardon, D. A. (2010). DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL. In NEURO-ONCOLOGY (Vol. 12, pp. 51–51). Hollywood, FL: OXFORD UNIV PRESS INC.
Desjardins, Annick, Katherine B. Peters, James J. Vredenburgh, Henry S. Friedman, and David A. Reardon. “DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL.” In NEURO-ONCOLOGY, 12:51–51. OXFORD UNIV PRESS INC, 2010.
Desjardins A, Peters KB, Vredenburgh JJ, Friedman HS, Reardon DA. DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 51–51.
Desjardins, Annick, et al. “DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL.” NEURO-ONCOLOGY, vol. 12, OXFORD UNIV PRESS INC, 2010, pp. 51–51.
Desjardins A, Peters KB, Vredenburgh JJ, Friedman HS, Reardon DA. DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 51–51.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

November 1, 2010

Volume

12

Start / End Page

51 / 51

Location

Hollywood, FL

Publisher

OXFORD UNIV PRESS INC

Conference Name

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences